Jordan J Elm
Affiliation: Medical University of South Carolina
- Design innovations and baseline findings in a long-term Parkinson's trial: the national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long-Term Study-1Jordan J Elm
Division of Biostatistics and Epidemiology, Medical University of South Carolina, 135 Cannon Street, Suite 303, PO Box 250835, Charleston, SC 29425, USA
Mov Disord 27:1513-21. 2012....
- Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trialJordan J Elm
Medical University of South Carolina, Charleston, SC, USA
J Biopharm Stat 22:758-72. 2012..The flexibility to add a treatment arm to an ongoing trial may result in cost savings as treatments that become ready for testing can be added to ongoing studies...
- A responsive outcome for Parkinson's disease neuroprotection futility studiesJordan J Elm
Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, SC 29425, USA
Ann Neurol 57:197-203. 2005....
- Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experienceJordan J Elm
Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA
Mov Disord 22:822-7. 2007..The most common approach to assessment is to do a pill count at each visit. The simple, 4-question Morisky medication adherence questionnaire may provide an alternative approach to monitoring treatment adherence in PD...
- Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trialsPaulo Guimaraes
Dept of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, 135 Cannon St Suite 303, Charleston, SC 29425, USA
Clin Trials 2:509-18. 2005..Models can help better understand behavior of the UPDRS after initiation of symptomatic therapy when scores will improve and eventually start deteriorating again...
- How common is brain atrophy in patients with medial temporal lobe epilepsy?Leonardo Bonilha
Division of Neurology, Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA
Epilepsia 51:1774-9. 2010..This study aimed to evaluate where and how much atrophy is to be expected in an individual patient with MTLE...